DelveInsight’s “Vaso-Occlusive Crisis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Vaso-Occlusive Crisis, historical and forecasted epidemiology as well as the Vaso-Occlusive Crisis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Vaso-occlusive Crisis Overview
A vaso-occlusive crisis is a common painful complication of sickle cell anemia in adolescents and adults. It is a form of sickle cell crisis. Sickle cell anemia – most common in those of African, Hispanic, and Mediterranean origin – leads to a sickle cell crisis when the circulation of blood vessels is obstructed by sickled red blood cells, causing ischemic injuries. The most common complaint is pain, and recurrent episodes may cause irreversible organ damage. One of the most severe forms is acute chest syndrome which occurs as a result of infarction of the lung parenchyma. This can rapidly result in death. Other types of vaso-occlusive crisis in sickle cell anemia include dactylitis, priapism, abdominal pain, and jaundice.
Vaso-occlusive Crisis Epidemiology Insights
-
Patient demographics included a mix of pediatric-only (< 18 years; 15 studies), adult-only (≥ 18 years; 14 studies), and mixed pediatric and adult (23 studies).
Click here to learn more about the Vaso-occlusive Crisis Market Landscape
The Report Covers the Vaso-occlusive Crisis Epidemiology Segmented by:
-
Vaso-occlusive Crisis total prevalent cases
-
Vaso-occlusive Crisis total diagnosed cases
-
Vaso-occlusive Crisis gender-specific diagnosed prevelant cases
-
Vaso-occlusive Crisis gene-specific diagnosed prevalent cases
Vaso-occlusive Crisis Market Outlook
The Vaso-Occlusive Crisis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Vaso-Occlusive Crisis market trends by analyzing the impact of current Vaso-Occlusive Crisis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Vaso-Occlusive Crisis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Vaso-Occlusive Crisis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Vaso-Occlusive Crisis market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Vaso-occlusive Crisis Market
-
Mast Therapeutics
-
Global Blood Therapeutics
-
Modus Therapeutics
-
Forma Therapeutics
And many others
Vaso-occlusive Crisis Therapies Covered and Analyzed in the Report:
-
Saline
-
MST-188
-
Inclacumab
-
L-citrulline
And many others
Learn more about the Key Companies and Emerging Therapies in the Vaso-occlusive Crisis Market
Table of Contents
-
Key Insights
-
Vaso-occlusive Crisis Introduction
-
Executive Summary of Vaso-occlusive Crisis
-
Disease Background and Overview
-
Epidemiology and patient population
-
Vaso-occlusive Crisis Emerging Therapies
-
Vaso-occlusive Crisis Market Outlook
-
Market Access and Reimbursement of Therapies
-
Market Drivers
-
Market Barriers
-
Appendix
-
Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
Learn about the detailed offerings of the report @ Vaso-occlusive Crisis Market Outlook
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services